Profile data is unavailable for this security.
About the company
Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The Company supplies products to hospitals, institutions as well as wholesalers and pharmacies.
- Revenue in DKK (TTM)25.00bn
- Net income in DKK4.87bn
- Incorporated1957
- Employees15.75k
- LocationColoplast A/SHoltedam 1-3HUMLEBAEK 3050DenmarkDNK
- Phone+45 49111111
- Fax+45 49111555
- Websitehttps://www.coloplast.dk/
More ▼
Mergers & acquisitions
| Acquired company | COLO B:CPH since announced | Transaction value |
|---|---|---|
| Kerecis Ltd | 8.82% | 1.30bn |
Data delayed at least 15 minutes, as of Apr 19 2024 15:59 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ypsomed Holding AG | 3.91bn | 556.46m | 39.86bn | 2.20k | 71.54 | 9.04 | 34.70 | 10.20 | 5.31 | 5.31 | 37.31 | 42.03 | 0.5888 | 4.92 | 5.75 | 247,016.00 | 8.38 | 4.44 | 12.70 | 6.77 | 32.04 | 26.95 | 14.24 | 6.87 | 0.5577 | 30.61 | 0.2614 | 18.54 | 7.02 | 1.31 | 121.92 | -0.3034 | 20.32 | -1.47 |
| SCHOTT Pharma AG & Co KgaA | 6.76bn | 1.18bn | 42.26bn | 4.65k | 35.82 | 7.87 | 27.35 | 6.25 | 1.05 | 1.05 | 6.01 | 4.78 | -- | -- | -- | 194,928.30 | -- | -- | -- | -- | 35.23 | -- | 17.48 | -- | 1.08 | -- | 0.094 | -- | 9.43 | -- | 21.11 | -- | -- | -- |
| ConvaTec Group PLC | 15.02bn | 913.53m | 50.73bn | 10.13k | 55.61 | 4.27 | 20.97 | 3.38 | 0.051 | 0.051 | 0.8394 | 0.6641 | 0.5865 | 2.57 | 6.14 | 170,093.30 | 3.57 | 2.36 | 4.18 | 2.73 | 56.04 | 76.98 | 6.08 | 4.34 | 0.8835 | 2.65 | 0.4367 | 127.29 | 3.37 | 3.18 | 107.15 | -6.93 | 12.37 | 31.41 |
| Amplifon SpA | 16.86bn | 1.16bn | 52.38bn | 14.38k | 44.96 | 6.36 | 16.64 | 3.11 | 0.6898 | 0.6898 | 10.02 | 4.88 | 0.6219 | 20.99 | 10.38 | 157,179.50 | 4.27 | 4.31 | 6.16 | 5.81 | 23.56 | 59.01 | 6.86 | 7.28 | 0.4519 | 6.31 | 0.5795 | 34.26 | 6.65 | 10.66 | -12.21 | 9.08 | 12.68 | 15.68 |
| Carl Zeiss Meditec AG | 15.63bn | 2.07bn | 65.17bn | 4.82k | 31.51 | -- | 106.98 | 4.17 | 3.10 | 3.10 | 23.45 | -- | -- | -- | -- | 434,177.70 | -- | 9.56 | -- | 11.72 | 57.35 | 57.84 | 13.28 | 13.15 | -- | -- | -- | 34.47 | 9.80 | 10.28 | -1.20 | 18.09 | 26.79 | 14.87 |
| Demant A/S | 22.44bn | 2.55bn | 68.76bn | 21.62k | 27.19 | 7.41 | -- | 3.06 | 11.44 | 8.05 | 100.58 | 41.97 | 0.7431 | 2.05 | 5.88 | 1,037,923.00 | 8.46 | 8.27 | 12.20 | 13.23 | 73.72 | 74.14 | 11.38 | 11.34 | 0.9529 | 5.98 | 0.6075 | 0.00 | 13.89 | 10.00 | 12.23 | 6.96 | 8.80 | -- |
| Smith & Nephew plc | 38.90bn | 1.84bn | 73.76bn | 18.45k | 39.94 | 2.01 | 11.12 | 1.90 | 0.2423 | 0.2423 | 5.11 | 4.81 | 0.5562 | 0.7522 | 4.33 | 241,838.00 | 2.64 | 4.10 | 3.29 | 4.99 | 68.82 | 71.39 | 4.74 | 8.02 | 0.72 | 4.84 | 0.3715 | 79.59 | 6.40 | 2.50 | 17.94 | -16.88 | 4.24 | -8.12 |
| Sonova Holding AG | 28.01bn | 4.61bn | 113.95bn | 17.64k | 24.75 | 7.03 | 17.37 | 4.07 | 10.05 | 10.05 | 61.01 | 35.39 | 0.6887 | 2.44 | 7.04 | 206,996.80 | 11.56 | 10.87 | 14.70 | 13.94 | 71.77 | 71.75 | 16.78 | 17.80 | 0.9036 | 24.86 | 0.4646 | 34.54 | 11.13 | 7.16 | 1.08 | 9.79 | 9.89 | 12.09 |
| Koninklijke Philips NV | 135.58bn | -3.40bn | 128.80bn | 69.66k | -- | 1.42 | 23.84 | 0.95 | -0.4979 | -0.5097 | 19.55 | 13.27 | 0.6047 | 2.84 | 4.63 | 260,853.30 | -1.51 | 0.3678 | -2.07 | 0.5013 | 41.00 | 43.84 | -2.49 | 0.6049 | 0.7782 | 5.36 | 0.3893 | -- | 1.92 | 0.0529 | 71.87 | -- | -5.24 | -- |
| Sartorius Stedim Biotech SA | 20.27bn | 1.90bn | 152.23bn | 10.60k | 76.74 | 5.04 | 39.45 | 7.51 | 2.73 | 2.73 | 29.11 | 41.57 | 0.4013 | 1.60 | 7.82 | 254,764.60 | 3.81 | 11.87 | 4.55 | 15.12 | 42.98 | 50.96 | 9.49 | 17.44 | 1.24 | 6.59 | 0.452 | 18.73 | -20.53 | 18.02 | -64.65 | 8.28 | 21.82 | 3.90 |
| Straumann Holding AG | 18.53bn | 1.89bn | 164.68bn | 11.11k | 87.18 | 11.67 | 56.84 | 8.89 | 1.54 | 1.54 | 15.11 | 11.52 | 0.7204 | 1.81 | 4.29 | 217,105.00 | 7.37 | 10.68 | 9.86 | 13.63 | 74.15 | 74.95 | 10.23 | 15.15 | 1.43 | 6.72 | 0.1968 | 37.50 | 3.92 | 12.08 | -43.40 | -2.04 | 11.54 | 10.12 |
| Coloplast A/S | 25.00bn | 4.87bn | 188.38bn | 15.75k | 39.94 | 13.32 | 31.48 | 7.53 | 22.44 | 22.44 | 115.20 | 67.27 | 0.5794 | 2.40 | 5.99 | 1,593,232.00 | 11.28 | 20.45 | 17.11 | 29.69 | 66.74 | 67.91 | 19.47 | 21.73 | 0.3462 | 11.08 | 0.5885 | 91.08 | 8.51 | 8.29 | 1.64 | 4.46 | 13.15 | 5.59 |
| Siemens Healthineers AG | 162.51bn | 11.33bn | 430.78bn | 71.40k | 37.86 | 3.20 | 18.95 | 2.65 | 1.35 | 1.35 | 19.33 | 15.98 | 0.4727 | 3.19 | 3.88 | 306,746.50 | 3.33 | 4.88 | 4.52 | 6.60 | 35.89 | 37.82 | 7.04 | 9.22 | 0.75 | 23.00 | 0.4721 | 54.89 | -0.1566 | 10.05 | -25.96 | 3.59 | 9.60 | 18.98 |
Data as of Apr 19 2024. Currency figures normalised to Coloplast A/S's reporting currency: Danish Krone DKK
12.69%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fundsmith LLPas of 30 Jun 2023 | 6.64m | 3.16% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 4.60m | 2.19% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 3.14m | 1.50% |
| BlackRock Investment Management (UK) Ltd.as of 29 Feb 2024 | 2.38m | 1.13% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 2.11m | 1.01% |
| Allianz Global Investors GmbHas of 31 Jan 2024 | 1.83m | 0.87% |
| Geode Capital Management LLCas of 11 Apr 2024 | 1.63m | 0.78% |
| Comgest SAas of 29 Dec 2023 | 1.61m | 0.77% |
| Walter Scott & Partners Ltd.as of 11 Apr 2024 | 1.45m | 0.69% |
| Capital Research & Management Co. (World Investors)as of 31 Dec 2023 | 1.27m | 0.61% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
